Babies as young as six months old could be vaccinated against Covid-19 next year if tests on the Moderna vaccine prove to be safe and effective for infants and toddlers.
Parents in Australia have rushed this month to make an appointment for a teen vaccination, as the Moderna vaccine has finally become available. You can make a reservation by going online to findapharmacy.com.au or by contacting the participating pharmacies.
But manufacturers are testing its use in children under the age of 5 and are also considering making the vaccine in Australia.
Moderna's chief medical adviser, Dr. Paul Burton, told News Corp that two-year-olds could be vaccinated.
"At the moment, it is approved for use in adults and children over the age of 12 and we will definitely go for younger babies," he said.
"I think we will have the test results just before the end of the year, maybe in November."
However, trials in the United States continue to vaccinate children as young as two years old, offering vaccines to children as young as six months.
Moderna Inc. plans to enroll about 13.275 participants in the child vaccine trial - with participants between the ages of six months and 12 years.
One of the scientists who participated in this study in the US, Katherine Luzuriaga, MD, said she was confident that thousands of parents would offer their consent for their children's participation.
"Getting children back to school… and protecting them as much as possible from infection is really important," said Dr Luzuriaga.
"We are focusing on medical issues, certainly on the risk of the disease itself and the long-term effects of COVID-19. However, what has been seen is that children have really suffered socially, emotionally and academically from not being able to go to school. "
"Until vaccines are approved for use in school-age children and more adolescents are vaccinated, we want to encourage parents and families to do what they can to protect their children, especially as they return to school." .
In April, Moderna filed a quarterly report on United States to the federal financial regulator, confirming that it will test the safety and efficacy of the Covid-19 vaccine in 6000 healthy children aged between six months and 12 years.
In August, the company confirmed that it was considering using Australia as a testing ground for children as young as six months old, but that would require approval from health authorities.
Source of information: news.com.au